14-3-3 protein plays crucial roles in tumorigenesis, including the maintenance of cell cycle and DNA repair, the prevention of apoptosis, among others. In mammalian cells, seven 14-3-3 isoforms (β, ε, ζ, η, θ, γ and σ) have been identified and each of these seems to have distinct tissue localizations and isoform-specific functions. In the present study, the levels of all seven 14-3-3 isoforms were examined in astrocytoma.
The expression of 14-3-3 isoforms and their protein expression levels were examined in five glioma cell lines by western blotting. Then in astrocytoma tissues, we investigated expression percentages of each isoform by immunohistochemistry. The protein and mRNA expression levels of each isoform were also detected by western blotting and RT-PCR, respectively.
14-3-3β and η were specifically expressed in astrocytoma, and their expression frequencies and levels increased with the increase of astrocytoma malignancy. The result from glioma cell lines was consistent with that from astrocytoma tissue.
In our study, we found two tumor-specific isoforms of 14-3-3 in astrocytoma. They might be involved in astrocytoma tumorigenesis and may be useful as targets for therapy.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the Neurological Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The conditional probability of survival of patients with primary malignant brain tumors: Surveillance, Epidemiology, and End Results (SEER) data.Cancer. 1999; 85: 485-491
- Brain tumors.N Engl J Med. 2001; 344: 114-123
- Recent developments in the use of chemotherapy in brain tumours.Eur J Cancer. 2006; 42: 582-588
- 14-3-3 proteins: key regulators of cell division, signaling and apoptosis.Bioessays. 2001; 23: 936-946
- 14-3-3 proteins and growth control.Prog Cell Cycle Res. 2000; 4: 49-60
- 14-3-3 proteins: structure, function, and regulation.Annu Rev Pharmacol Toxicol. 2000; 40: 617-647
- Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants.Plant Mol Biol. 2002; 50: 993-1010
- 14-3-3 proteins: regulation of subcellular localization by molecular interference.Cell Signal. 2000; 12: 703-709
- 14-3-3 proteins in neuronal development and function.Mol Neurobiol. 1998; 16: 269-284
- Human cruciform binding protein belongs to the 14-3-3 family.Biochemistry. 1998; 37: 14317-14325
- Immunocytochemical detection of 14-3-3 in primary nervous system tumors.J Neuro-oncol. 2006; 77: 125-130
- The 2007 WHO classification of tumours of the central nervous system.Acta Neuropathol. 2007; 114: 97-109
- Human: 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders.J Neurochem. 1982; 38: 1475-1482
- Purification, properties, and immunohistochemical localisation of human brain 14-3-3 protein.J Neurochem. 1982; 38: 1466-1474
- Connecting proliferation and apoptosis in development and disease.Nat Rev Mol Cell Biol. 2004; 5: 805-815
- Tumor angiogenesis: vascular growth and survival.APMIS. 2004; 112: 431-440
- Identification of a novel interaction between integrin β1 and 14-3-3β.Oncogene. 2001; 20: 346-357
- Binding of 14-3-3beta regulates the kinase activity and subcellular localization of testicular protein kinase 1.J Biol Chem. 2001; 276: 43471-43481
- Binding of 14-3-3β to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population.Cell Growth Differ. 2000; 11: 211-219
- Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation.Carcinogenesis. 2000; 21: 2073-2077
- Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways.Semin Cancer Biol. 2006; 16: 193-202
- Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis.Exp Cell Res. 2001; 271: 142-151
- Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release.J Neurochem. 2000; 75: 2288-2297
- Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury.J Neurol Sci. 2000; 20: 7246-7251
- Bcl-2 targets protein phosphatase 1 alpha to Bad.J Immunol. 2001; 166: 7345-7352
- Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin-3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation.Blood. 2001; 97: 1289-1297
- Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.Brain Pathol. 1996; 6: 217-223
- Analysis of complex relationship between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.Cancer Res. 2001; 61: 1122-1128
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin.Nature. 1985; 313: 144-147
- Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis.J Neurol. 1995; 242: 683-688
- Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.J Neurosurg. 1996; 85: 634-641
- PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma.J Natl Cancer Inst. 2001; 93: 1246-1256
- Forced expression of antisense 14-3-3beta RNA suppresses tumor cell growth in vitro and in vivo.Carcinogenesis. 2003; 24: 1549-1559
- Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage.Nat Cell Biol. 2005; 7: 30-41
- Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors.Expert Rev Anticancer Ther. 2005; 5: 177-191
- 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades.EMBO J. 2000; 19: 349-358
- JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3.J Cell Biol. 2005; 170: 295-304
- Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-x(L) during apoptosis.J Biol Chem. 2003; 278: 19347-19351
- 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax.J Biol Chem. 2003; 278: 2058-2065
- Tenascin-C signaling through induction of 14-3-3 tau.J Cell Biol. 2003; 160: 171-175
Accepted: August 26, 2008
Received in revised form: August 20, 2008
Received: April 12, 2008
© 2008 Elsevier B.V. Published by Elsevier Inc. All rights reserved.